Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Sever

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|August 21, 2016
True Resistant Hypertension Following Observed Drug Ingestion: A Systematic EvaluationJill Bunker, Choon-Lan Chang, Neil Chapman, et al.
Lancet (London, England)|August 31, 2018
Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trialAjay Gupta, Judith Mackay, Andrew Whitehouse, et al.
Journal of Hypertension|February 2, 2016
Urinary catecholamines and the relationship with blood pressure and pharmacological therapyConstantinos G Missouris, Nirmala D Markandu, Feng J He, et al.
Archives of Internal Medicine|June 30, 2010
Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participantsKausik K Ray, Sreenivasa Rao Kondapally Seshasai, Sebhat Erqou, et al.
Ebiomedicine|June 5, 2025
The relationship of baseline high-sensitivity C-reactive protein with incident cardiovascular events and all-cause mortality over 20 yearsAdam Hartley, Somayeh Rostamian, Amit Kaura, et al.
Stroke|August 5, 2006
Candesartan- and atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertensionBen Ariff, Andrew Zambanini, Sarita Vamadeva, et al.
Journal of Human Hypertension|November 23, 2022
Management of hypertensive crisis: British and Irish Hypertension Society Position documentSpoorthy Kulkarni, Mark Glover, Vikas Kapil, et al.
Lancet (London, England)|November 13, 2020
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trialsBaris Gencer, Nicholas A Marston, KyungAh Im, et al.
The American Journal of Cardiology|February 7, 2009
Effect of beta blockers (metoprolol or propranolol) on effect of simvastatin in lowering C-reactive protein in acute myocardial infarctionJose C Quinaglia e Silva, Daniel B Munhoz, Tiago N Morato, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|September 14, 2002
Comparison of the effects of antihypertensive treatment with angiotensin II blockade and beta-blockade on carotid wall structure and haemodynamics: protocol and baseline demographicsBen Ariff, Alice Stanton, Dean Barratt, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Journal of Clinical Hypertension (Greenwich, Conn.)|August 21, 2016
True Resistant Hypertension Following Observed Drug Ingestion: A Systematic EvaluationJill Bunker, Choon-Lan Chang, Neil Chapman, et al.
Lancet (London, England)|August 31, 2018
Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trialAjay Gupta, Judith Mackay, Andrew Whitehouse, et al.
Journal of Hypertension|February 2, 2016
Urinary catecholamines and the relationship with blood pressure and pharmacological therapyConstantinos G Missouris, Nirmala D Markandu, Feng J He, et al.
Archives of Internal Medicine|June 30, 2010
Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participantsKausik K Ray, Sreenivasa Rao Kondapally Seshasai, Sebhat Erqou, et al.
Ebiomedicine|June 5, 2025
The relationship of baseline high-sensitivity C-reactive protein with incident cardiovascular events and all-cause mortality over 20 yearsAdam Hartley, Somayeh Rostamian, Amit Kaura, et al.
Stroke|August 5, 2006
Candesartan- and atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertensionBen Ariff, Andrew Zambanini, Sarita Vamadeva, et al.
Journal of Human Hypertension|November 23, 2022
Management of hypertensive crisis: British and Irish Hypertension Society Position documentSpoorthy Kulkarni, Mark Glover, Vikas Kapil, et al.
Lancet (London, England)|November 13, 2020
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trialsBaris Gencer, Nicholas A Marston, KyungAh Im, et al.
The American Journal of Cardiology|February 7, 2009
Effect of beta blockers (metoprolol or propranolol) on effect of simvastatin in lowering C-reactive protein in acute myocardial infarctionJose C Quinaglia e Silva, Daniel B Munhoz, Tiago N Morato, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|September 14, 2002
Comparison of the effects of antihypertensive treatment with angiotensin II blockade and beta-blockade on carotid wall structure and haemodynamics: protocol and baseline demographicsBen Ariff, Alice Stanton, Dean Barratt, et al.
Pageof 12